Zobrazeno 1 - 10
of 190
pro vyhledávání: '"HAJIME BABA"'
Autor:
Taro Kishi, Kenji Sakuma, Masakazu Hatano, Takenori Okumura, Masaki Kato, Hajime Baba, Nakao Iwata
Publikováno v:
Neuropsychopharmacology Reports, Vol 44, Iss 1, Pp 267-271 (2024)
Abstract Aim To update the major depressive disorder (MDD) treatment guidelines of the Japanese Society of Mood Disorders, we conducted a systematic review and pairwise meta‐analysis of double‐blind, randomized, placebo‐controlled trials of ava
Externí odkaz:
https://doaj.org/article/473c75bb15464286a3387b7057e954ba
Autor:
Yumi Aoki, Yoshikazu Takaesu, Hajime Baba, Jun‐ichi Iga, Hikaru Hori, Takeshi Inoue, Kazuo Mishima, Aran Tajika, Masaki Kato
Publikováno v:
Neuropsychopharmacology Reports, Vol 42, Iss 3, Pp 306-314 (2022)
Abstract Aim While evidence‐based antidepressant treatment is available for major depressive disorder, standard approaches for discontinuation of antidepressants after remission have not yet been established. Decision aids are structured clinical t
Externí odkaz:
https://doaj.org/article/dfbc156f9049413f839e36721145537b
Autor:
Hajime Baba
Publikováno v:
PCN Reports, Vol 2, Iss 2, Pp n/a-n/a (2023)
Abstract With the unprecedented aging of the world's population, the number of elderly patients with depression is expected to increase. However, management and treatment of late‐life depression (LLD) is more difficult than in early adults. Prior t
Externí odkaz:
https://doaj.org/article/fee2a3ac0b1a49b6b70c40f469f1be0e
Publikováno v:
International Journal of Alzheimer's Disease, Vol 2011 (2011)
A recent paper reported that Aβ oligomer causes neuronal cell death through the phosphatidylinositol-3-OH kinase (PI3K)-Akt-mTOR signaling pathway. Intraneuronal Aβ, a main pathological finding of Alzheimer's disease (AD), is also known as inhibiti
Externí odkaz:
https://doaj.org/article/e49efde3c719438d92c933927292ca40
Autor:
Hajime, Baba, Shinsuke, Kito, Kazutaka, Nukariya, Minoru, Takeshima, Noboru, Fujise, Junichi, Iga, Hidehiro, Oshibuchi, Masahiko, Kawano, Mahiko, Kimura, Katsuyoshi, Mizukami, Masaru, Mimura
Publikováno v:
Psychiatry and Clinical Neurosciences. 76:222-234
The Committee for Treatment Guidelines of Mood Disorders, Japanese Society of Mood Disorders, published a Japanese guideline for the treatment of late-life depression in 2020. Based on that guideline, the present guideline was developed and revised t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aaf0f3c571839945005668002434e68a
https://doi.org/10.1111/pcn.13349
https://doi.org/10.1111/pcn.13349
Autor:
Masaki Kato, Hajime Baba, Yoshiteru Takekita, Minami Naito, Yosuke Koshikawa, Hiroki Bandou, Toshihiko Kinoshita
Objective Mirtazapine and SSRIs are widely prescribed as first-line agents for late-life depression. However, evidence for these drugs is mostly based on non-elderly patients. Therefore, we reanalyzed a randomized controlled trial of mirtazapine vers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4d11d2bde79426d8944f67551d58a44b
https://doi.org/10.21203/rs.3.rs-2589875/v1
https://doi.org/10.21203/rs.3.rs-2589875/v1
Autor:
Takefumi Suzuki, Ikuko Kishida, Masaki Kato, Hiroyuki Uchida, Koichiro Watanabe, Yuka Sugawara Kikuchi, Hitoshi Sakurai, Asuka Katsuki, Toshiaki Kikuchi, Norio Yasui-Furukori, Hajime Baba, Ken Inada
Publikováno v:
Bipolar Disorders
Objectives The aim of this study was to develop a consensus guideline by certified experts of the Japanese Society of Clinical Neuropsychopharmacology on the psychopharmacological treatment for bipolar disorders I and II (BP‐I and BP‐II), in orde
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac739f4f757d57190c1c473badb3e952
https://doi.org/10.1111/bdi.12959
https://doi.org/10.1111/bdi.12959
Autor:
Shuntaro Natsume, Hajime Baba, Hitoshi Maeshima, Takao Saida, Naoto Yoshinari, Kentaro Shimizu, Toshihito Suzuki
Publikováno v:
Journal of affective disorders. 315
Depression is known to be a risk factor for Alzheimer's disease (AD). Changes in amyloid β protein (Aβ) metabolism have been speculated as a factor contributing to the transition from depression to AD. The aim of this study is to reveal the time co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b25b7a6f39db0058c380a39e703cccdc
https://pubmed.ncbi.nlm.nih.gov/35932935
https://pubmed.ncbi.nlm.nih.gov/35932935
Publikováno v:
Food Bioscience. 50:102186
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75641bf0c8492aed8689f482afe06be8
https://doi.org/10.1016/j.fbio.2022.102186
https://doi.org/10.1016/j.fbio.2022.102186
Autor:
Shuntaro Natsume, Takao Saida, Megumi Inoue, Takahisa Shimano, Toshihito Suzuki, Hajime Baba, Hitoshi Maeshima, Hiroko Shukuzawa
Publikováno v:
Juntendo Medical Journal. 66:424-430
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f2f975360a4523c01d7f852c005b07e
https://doi.org/10.14789/jmj.2020.66.jmj20-oa02
https://doi.org/10.14789/jmj.2020.66.jmj20-oa02